Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma

Gynecologic Oncology

Volumn 113, Issue 2, 2009, Pages 176-180

  Cannon, G M ^a   Geye, H ^a   Terakedis, B E ^a   Kushner, D M ^b   Connor, J P ^b   Hartenbach, E M ^b   Bradley, K A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adenocarcinoma; Adjuvant radiation; Endometrial cancer; Hysterectomy; Stage II; Vaginal cuff brachytherapy

Indexed keywords

ABDOMINAL HYSTERECTOMY; ACUTE TOXICITY; ARTICLE; AVASCULAR NECROSIS; BLEEDING; BLOATING; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; DIARRHEA; DISEASE FREE SURVIVAL; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FEMUR HEAD; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LYMPH NODE DISSECTION; LYMPH VESSEL; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MYOMETRIUM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RECTUM HEMORRHAGE; RECURRENCE RISK; RISK ASSESSMENT; SMALL INTESTINE OBSTRUCTION; SURGICAL APPROACH; URINARY FREQUENCY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 63949083611     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.12.029     Document Type: Article

References (15)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J. Clin. 58 2 (2008, Mar-Apr) 71-96
2. Creasman W.T., Odicino F., Maisonneuve P., Quinn M.A., Beller U., Benedet J.L., et al. Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 95 Suppl 1 (2006, Nov) S105-S143
3. Benedet J.L., Bender H., Jones III H., Ngan H.Y., and Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet. 70 2 (2000, Aug) 209-262
4. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 355 9213 (2000, Apr 22) 1404-1411
5. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol. Oncol. 92 3 (2004, Mar) 744-751
6. Small Jr. W., Erickson B., and Kwakwa F. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 63 5 (2005, Dec 1) 1502-1507
7. Nag S., Erickson B., Parikh S., Gupta N., Varia M., and Glasgow G. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int. J. Radiat. Oncol. Biol. Phys. 48 3 (2000, Oct 1) 779-790
8. Pitson G., Colgan T., Levin W., Lockwood G., Manchul L., Milosevic M., et al. Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients. Int. J. Radiat. Oncol. Biol. Phys. 53 4 (2002, Jul 15) 862-867
9. Blake P., Lodge N., A R.P., and Hern. An audit of outcome of adjuvant post-operative radiotherapy for 52 women with stage II carcinoma of the endometrium. Br. J. Radiol. 73 873 (2000, Sep) 987-993
10. Cozad S.C. Stage II adenocarcinoma of the endometrium: adjuvant radiotherapy and recurrence patterns. Int. J. Radiat. Oncol. Biol. Phys. 71 1 (2008, May 1) 205-212
11. Nout R.A., Putter H., Jurgenliemk-Schulz I.M., Jobsen J.J., Lutgens L.C., van de Steen-Banasik E., et al. Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: results of the randomized PORTEC-2 trial. J. Clin. Oncol. 26 May 20 suppl (2008) LBA5503
12. Calvin D.P., Connell P.P., Rotmensch J., Waggoner S., and Mundt A.J. Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am. J. Clin. Oncol. 22 4 (1999, Aug) 338-343
13. Greer B.E., and Koh W.-J. Uterine neoplasms. Pract. Guidel. Oncol. (2008). http://www.nccn.org [serial on the Internet]. 2008; v.1.2008: Available from: www.nccn.org
14. Cohn D.E., Woeste E.M., Cacchio S., Zanagnolo V.L., Havrilesky L.J., Mariani A., et al. Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet. Gynecol. 109 5 (2007, May) 1062-1067
15. Ayhan A., Taskiran C., Celik C., and Yuce K. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol. Oncol. 93 1 (2004, Apr) 9-13